BrainFutures reviewed the research and selected rele- vant studies to summarize in our report—the majority of which not only had valid study designs and meth- odologies, but also worked with human subjects and investigated the use of these compounds as effective or efficacious treatments in participants with ongoing and hard-to-treat MH/SUDs. In total, BrainFutures outlines and summarizes more than 200 peer-reviewed publications involving psychedelics, including 46 randomized controlled trials (RCTs) and 47 open-label studies with more than 4,000 participants, in addition to eight meta-analyses and 84 reviews.
Filters
Close